Not financial advice. Just my watchlist and trade plan. These are high-risk penny/small-cap setups, so I’m treating them as trades, not investments.

SHORT WATCHLIST

1. SANA — short bias

Watching $3.00 closely. If SANA loses $3.00 with volume, I’m looking for downside continuation toward the $2.85–$2.70 area. I do not want to chase if it reclaims strength.

My watch levels:

• Short watch: under $3.00
• Better confirmation: failed reclaim of $3.07–$3.14
• First downside target: $2.85
• Stretch target: $2.70
• Stop idea: reclaim over $3.18

Reasoning: high short interest, weak biotech tape potential, and a clear psychological level at $3.00. Main risk is a headline-driven squeeze.

2. ALLO — short bias

Watching the $2.00 area. If ALLO fails to hold $2.00 or rejects around it, I’m looking for a fade toward the high-$1s.

My watch levels:

• Short watch: failed hold of $2.00
• Better confirmation: breakdown under $1.97
• First downside target: $1.85
• Stretch target: $1.75
• Stop idea: reclaim over $2.16

Reasoning: weak price action near a major psychological level. I’m not shorting blindly, but a clean loss of $2.00 could trigger more downside.

3. CCCC — short bias

Watching $3.50 as the first key level. If CCCC loses that and cannot reclaim, I’m looking for a move toward $3.30, then possibly $3.05.

My watch levels:

• Short watch: under $3.50
• Better confirmation: loss of $3.28
• First downside target: $3.30
• Stretch target: $3.05
• Stop idea: reclaim over $3.74

Reasoning: looking for rejection/fade behavior after weakness. I want volume confirmation because CCCC can still squeeze if buyers step in.

LONG WATCHLIST

4. WTO — long bias

I’m still watching WTO from the long side, but I’m not reposting the full price plan here. Go back and see my most recent post for the WTO DD and levels.

Overall thesis

For the shorts, I’m watching for biotech weakness, failed bounces, and breakdowns through clean levels:

• SANA: short watch under $3.00
• ALLO: short watch around/under $2.00
• CCCC: short watch under $3.50
• WTO: long watch — see my most recent WTO DD post

Penny stocks are not “buy and hope” names. Dilution, offerings, reverse split risk, biotech PR, and pump-and-dump behavior are always on the table. Trade the levels, respect stops, and don’t marry penny stocks.

I know, I know...I am still on $WTO but it's just looking like a really solid option. I am just having a hard time identifying where the bottom is before it becomes violent again.

Not financial advice. I’m watching WTO closely Monday after Friday’s weak/slow bleed into the $0.79 close.

Key levels I’m watching:

• $0.75 = Friday low / must-hold support
• $0.84 = first reclaim level
• $0.89 = stronger confirmation level
• $0.96–$1.00 = obvious compliance/sentiment magnet
• $1.07–$1.14 = next resistance zone if volume shows up

The stock had a big move recently from around $1.80s to $3.50s, so it has shown it can move when momentum/liquidity hits. That said, I’m not treating this as a blind squeeze play. There has been no new company PR that I’ve seen since the May 11 due-diligence update on the proposed Feixiaohao transaction, so Monday needs real volume confirmation.

My read:
WTO is oversold and could get scanner attention if it starts reclaiming levels, but under $0.84 it’s still just a weak chart. Over $0.89, I’d start watching for a push toward $1.00. If it clears $1.00 with volume, then it gets more interesting.

Risks are real: recent offering/warrant overhang, prior reverse split history, and the usual microcap dilution risk. I’m watching for volume, not hype.

My plan:
No chase under $0.84. Watch $0.84 → $0.89 → $1.00. Cut thesis if $0.75 fails.

Curious who else is watching WTO Monday and what levels you have.

Not financial advice. Posting my current trade notes and looking for pushback. These are all high-risk names, and I’m treating them as trades, not long-term investments.

$IOVA — short-biased tactical setup

Resistance:
$3.56
$3.65
$3.80
$4.00
$4.15

Support:
$3.50
$3.40
$3.25
$3.00

Signal:
Short thesis is strongest if it stays below $3.56 and especially if $3.50 breaks with volume.

Why I’m watching:
There was a large after-hours print around $3.56, so I’m treating that as the key pivot/control level. If price stays below it, sellers may still be in control. If it reclaims $3.65, I’d be more cautious.

Plan:
Short below $3.56 / add only below $3.50 or on failed bounce into $3.65–$3.80.
Targets: $3.40, $3.25, $3.00.
Risk: above $3.85 gets sketchy; above $4.15 likely invalidates the short.

$CABA — dilution-anchor short thesis

Resistance:
$3.80
$4.00
$4.25
$4.50

Support:
$3.60
$3.45
$3.25
$2.90

Signal:
Short if it fails $3.80–$4.00 or breaks $3.60.

Why I’m watching:
CABA recently priced a large offering at $2.90/share, so I’m treating $2.90 as the dilution anchor. If the market stops supporting it above the deal price, downside could open up.

Plan:
Short failed move into $3.80–$4.00.
Add only if $3.60 breaks.
Targets: $3.45, $3.25, $2.90–$3.00.
Risk: above $4.25, short thesis is in trouble.

Main risk:
Active biotech headline/catalyst risk. This can squeeze if news hits.

$BMEA — crowded short / breakdown watch

Resistance:
$1.65
$1.80
$2.00

Support:
$1.50
$1.35
$1.20

Signal:
Short if it fails $1.65–$1.80 or breaks $1.50.

Why I’m watching:
BMEA has a lot of short interest relative to its float, so it can work both ways. If $1.50 breaks, downside could accelerate. But if it reclaims $1.80–$2.00, shorts could get squeezed.

Plan:
Short failed $1.65 reclaim or $1.50 breakdown.
Targets: $1.45, $1.35, $1.20.
Risk: above $1.80; hard risk above $2.00.

$DLTH — already in this short, slow grind setup

Resistance:
$3.00
$3.25
$3.50
$4.00

Support:
$2.85
$2.60
$2.30
$2.00

Signal:
Short thesis remains valid below $3.00.

Why I’m watching:
DLTH is not a high-drama squeeze setup for me. It’s more of a slow failed-retail/small-cap short. If it stays below $3.00, I think sellers remain in control. If it breaks $2.85, $2.60 becomes realistic.

Plan:
Hold short below $3.00.
Add only if $2.85 breaks with volume.
Targets: $2.60, $2.30, $2.00.
Risk: reclaim above $3.25; hard risk above $3.50.

$WTO — long, underwater, speculative low-float recovery setup

Resistance:
$1.20
$1.50
$2.00
$2.50
$3.50

Support:
$1.00
$0.95
$0.80
$0.70

Signal:
Long thesis only survives if $1.00 holds. Real momentum does not start unless $1.20 reclaims, and confirmation is above $1.50.

Why I’m watching:
This is a post-dilution low-float setup with an active Feixiaohao transaction storyline. The upside thesis is not a classic short squeeze; it’s more of a low-float momentum swing if volume hits.

Plan:
Do not add below $1.20.
Watch for reclaim of $1.20, then $1.50.
Recovery targets: $2.00, $2.50, then $3.50 if volume goes crazy.
Risk: if $1.00 fails and cannot reclaim, the long thesis weakens badly.

Summary

Best tactical short: $IOVA
Best dilution-anchor short: $CABA
Best breakdown short: $BMEA
Slow-grind short: $DLTH
Speculative long/squeeze setup: $WTO

Again, not financial advice. These are trade plans with defined levels. Happy to hear opposing DD.

Not financial advice. Looking at $CABA as a possible short/swing trade because of the recent offering, but this one has more headline risk than a normal dilution fade.

Quick DD

Cabaletta Bio recently priced a major underwritten offering: 51,725,000 shares at $2.90/share, raising about $150M gross proceeds. The company said the offering was expected to close around May 5, 2026. That $2.90 level is the key anchor for my thesis. ()

This is a huge amount of new supply relative to a sub-$5 biotech. The bearish idea is simple: if the market stops treating the financing as validation, the stock can drift back toward the offering price.

But there is an important counterpoint: this was not just a toxic-looking emergency raise. The company’s financing included institutional participation, and the cash is expected to help fund rese-cel development and commercial readiness into mid-2027. ()

Catalyst risk

CABA also has active ASGCT 2026 exposure. The company announced multiple presentations for ASGCT 2026, held May 11–15, 2026, including manufacturing, translational, and clinical data related to rese-cel. ()

Separately, CABA and Cellares announced a 10-year commercial supply agreement, and Cabaletta said it anticipated reporting initial translational data with Cellares-manufactured rese-cel at ASGCT in May 2026. ()

That means this is not a “short and forget” name this week. There is real headline/squeeze risk.

Technical setup

Current area I’m watching: around $3.75–$3.90

Resistance

• $3.95–$4.00 = immediate psychological resistance
• $4.15–$4.25 = key rejection / short stop zone
• $4.50 = squeeze extension area
• $5.00 = major psychological upside level if catalyst momentum hits

Support

• $3.60–$3.65 = first support / first cover zone
• $3.45–$3.50 = second support
• $3.25–$3.35 = intermediate downside target
• $2.90 = offering price / dilution anchor
• $2.70–$2.75 = possible overshoot if sellers take control

Signal

The short thesis is valid as long as CABA keeps failing below $4.15–$4.25.

My preferred trigger is not just shorting blindly. I’d rather see:

1. Failed push into $3.95–$4.15
2. Loss of $3.60–$3.65
3. Volume fading after any ASGCT-related pop

Trade idea

Short entry: $3.80–$4.05 on failed bounce
Take profit 1: $3.60–$3.65
Take profit 2: $3.25–$3.35
Final target: $2.90–$3.00
Stop: $4.22 hard stop, or tighter above $4.05 for day trades

Why I’m watching it

Bearish reasons:

• Massive 51.725M-share offering
• Offering priced at $2.90, well below the recent trading area
• Dilution anchor may eventually pull price lower
• Under-$5 biotech with financing overhang
• If volume fades, the stock may drift toward the deal price

Bullish risks:

• Offering may be viewed as institutional validation, not just dilution
• Funding extends runway for development/commercial readiness
• Active ASGCT 2026 presentation window creates headline risk
• Cellares 10-year supply agreement gives bulls a real narrative
• A reclaim of $4.25 could trigger a squeeze

My read

CABA has the cleaner fundamental dilution-anchor short thesis, but it has more headline risk than IOVA right now.

For me:

Below $3.60 = downside thesis starts working
Below $3.25 = $2.90 becomes very realistic
Above $4.25 = short thesis is in trouble
Above $4.50 = possible squeeze mode

I would not short this without a hard stop because ASGCT headlines can move it fast.

Not financial advice. Looking at $IOVA as a tactical short setup, not a long-term fundamental call.

Quick DD

Iovance reported Q1 2026 results on May 7. The company showed real commercial progress, with about $71M in Q1 revenue, up roughly 45% year over year, including about $60M from Amtagvi and about $11M from Proleukin. Management guided Q2 revenue to $86M–$88M and FY2026 revenue to $350M–$370M. That is the bullish side of the story. ()

The bearish side is that the market did not like the quarter. IOVA reportedly missed on EPS, with GAAP EPS of -$0.19, missing by about $0.04, and revenue also came in below analyst expectations depending on the source. Shares were weak in reaction to the earnings report. ()

So this is not a “company is dead” short. It is more of a post-earnings technical fade while the chart remains weak.

Technical setup

Current area I’m watching: around $3.70–$3.85

Resistance

• $3.80–$3.85 = immediate intraday resistance
• $3.95–$4.00 = major psychological/rejection zone
• $4.10–$4.15 = short thesis invalidation zone
• $4.25+ = squeeze continuation risk

Support

• $3.70–$3.71 = key near-term support / moving-average area
• $3.65 = bear-flag breakdown confirmation
• $3.55 = first downside target
• $3.45–$3.50 = second downside target
• $3.25 = stretch target if selling volume expands

Signal

For me, the clean short trigger is a break and hold below $3.70, with stronger confirmation below $3.65.

I would not chase weakness straight into support unless volume confirms. The better short setups are:

1. Failed push into $3.80–$3.85
2. Rejection near $3.95–$4.00
3. Breakdown below $3.65 with volume

Trade idea

Short entry: $3.75–$3.85 on failed bounce, or below $3.65 on confirmation
Take profit 1: $3.55
Take profit 2: $3.45–$3.50
Stretch target: $3.25
Stop: $3.88 tight / $4.05–$4.15 wider

Why I’m watching it

Bearish reasons:

• Post-earnings weakness after Q1 results
• EPS miss
• Price is consolidating after a selloff instead of reclaiming $4
• Potential bear-flag structure if $3.65 breaks
• Under-$5 biotech momentum names can move hard once sellers regain control

Bullish risks:

• IOVA is not a no-revenue biotech; it has real product revenue
• Revenue grew strongly year over year
• Management guided FY2026 product revenue to $350M–$370M
• High short interest / crowded bearish positioning could create squeeze risk if $4 is reclaimed

My read

I like IOVA as a cleaner intraday short than many microcap bios because it has liquidity and clear levels. But I would not treat it like a zero. This is a technical short only while it stays below $4.00.

For me:

Below $3.65 = bearish confirmation
Above $4.00 = caution
Above $4.15 = short thesis probably invalid

I am still here on $WTO because I am starting to see changes.

Not financial advice. I’m long $WTO and fully recognize this is high-risk. Posting my DD/thesis and looking for pushback.

Quick setup

$WTO / UTime Limited recently got hit after a registered direct offering. The company announced a $1.2M registered direct offering for an aggregate of 1,000,000 Class A ordinary shares or pre-funded warrants in lieu thereof, priced at $1.20/share. The offering was expected to close around May 4, 2026. ()

That dilution is the obvious bear case and likely explains why the stock has been pinned around the $1 area. I am not ignoring that. This is not a “clean fundamental value” play to me. It is a high-risk, low-float momentum/swing trade.

Why I’m watching it

The main thing keeping me interested is that WTO has an active corporate catalyst in play. On May 11, 2026, UTime provided an update saying that financial, legal, and operational due diligence is ongoing for the proposed transaction with Feixiaohao Technology Inc. ()

Feixiaohao is the interesting part of the story because prior reporting described it as a Web3 data platform and referenced a proposed transaction valued up to $80M. () For a tiny Nasdaq microcap, that type of storyline can matter if the market starts to believe the transaction is advancing.

Two reasons I think a violent swing is possible

1. Tiny float / thin structure

StockTitan’s WTO overview currently lists float around 1.97M shares. () With a structure that thin, it does not take mega-cap-level volume to move the stock hard. If volume actually comes in, the price can move disproportionately fast.

1. Active catalyst thread

This is not just a dead ticker with no story. The company just gave an update that due diligence is progressing on the Feixiaohao transaction. () That does not mean the deal is guaranteed, but it gives traders a reason to watch for follow-up filings/news.

Levels I’m watching

$1.00 = must-hold psychological level
$1.20 = offering price / dilution anchor
$1.50 = first real momentum confirmation
$2.00 = major recovery level
$2.45–$2.50 = my personal full-trade recovery zone
$3.50 = prior visible supply area / possible squeeze target if volume gets crazy

For me, the key is $1.20. If WTO cannot reclaim the offering price, dilution is probably still in control. If it reclaims $1.20 and then breaks $1.50 with volume, the setup becomes much more interesting.

Bear case / risks

The recent offering is highly dilutive. The company sold stock/warrants into the market, and that supply may cap rallies. ()

WTO also has a reverse-split/dilution history, so this is not something I would treat like a long-term investment. This is a trade setup, not a marriage.

Also, this does not look like a classic short squeeze based on available short-interest data. The better thesis is low-float momentum squeeze, not “shorts are trapped.”

My thesis

I think WTO is a risky but interesting post-dilution setup. The market already knows about the offering. If the stock keeps holding around/above $1 and the Feixiaohao storyline gets follow-through, the float is thin enough that a volume spike could produce a violent move.

I’m watching for:

• Hold above $1.00
• Reclaim $1.20
• Break $1.50 with volume
• Follow-up news/filing on Feixiaohao

Again, high-risk. I’m not pretending the dilution is bullish. The bet is that the dilution washout may already be priced in, and the active transaction storyline + tiny float could create a sharp swing if buyers show up.

Sharing my current small-cap watchlist and positions for discussion. Not financial advice, not telling anyone to follow, and these are all high-risk/thinly traded names.

I’m currently watching three tickers: $DLTH, $IHRT, and $WTO.

$DLTH — short position

DLTH had a major earnings-related jump back on March 19, when it moved hard after reporting improved profitability and stronger margins. Since then, I’m watching whether that move continues to fade.

My short thesis here is mostly based on the idea that the earnings spike may have gotten ahead of itself, especially in a thinly traded name where price can move sharply on limited volume.

I’m looking at the $2.91 area as a potential first cover zone, though I still think a deeper retrace toward the $2.20 range is possible if momentum fully unwinds. Main issue: trading is thin, so exits can get messy.

$IHRT — short position

IHRT gapped after the report that Sirius XM was in preliminary talks involving a potential deal with iHeartMedia. My issue with that move is timing. Even if a deal eventually happens, this does not seem like something that would close quickly. It could take months, possibly longer, and there would likely be regulatory/debt/structure questions along the way.

IHRT already started moving back toward pre-news levels last week, so I’m watching for continued fade. My current target area to close is around $4.57.

$WTO — long / mid-term volatility watch

WTO is a different setup for me. I’m not long because I love the company. I’m long because the stock can move violently when volume shows up.

This one trades extremely thin most of the time, but when traders rotate into it, the swings can be huge. Recently it ran hard into the multi-dollar range, then faded back down sharply. Now it looks like it may be consolidating again.

To me, WTO is sitting in a decision zone. Because it is so thin, I think the next real move could be sharp in either direction. I’m watching for volume confirmation more than anything else.

My current view:

• DLTH: short, watching for post-earnings spike fade
• IHRT: short, watching for merger-news gap to keep unwinding
• WTO: long, watching for thin-float volatility and possible momentum return

Again, these are risky and thinly traded names. Position sizing and exits matter more than conviction here.

Anyone else watching these? What levels are you looking at?

Watching $WTO into after-hours and tomorrow, mostly from a chart structure standpoint.

Not calling this a buy or a price target, but the setup is interesting because price appears to be tightening after the earlier volume spike. On the chart, I’m seeing a potential compression pattern forming between rising support from the recent lows and descending resistance from the prior spike area. Price is also sitting near the short-term EMA area, which makes the next move worth watching. 

What I’m watching:

• Whether it can hold the $1.00–$1.04 area
• Whether volume comes back in after hours or at tomorrow’s open
• Whether price can reclaim and hold above the descending trendline / EMA area
• Whether it rejects again and breaks below the lower trendline instead

This is obviously a high-risk penny stock and not a long-term thesis for me. I’m mainly interested in whether the recent volume spike was just a one-off move or whether it leads to another attempt at continuation.

Curious what others are seeing here: tightening wedge before another push, or just fading volume before another leg down?

Consolidation? Apologies for the crude markup.

I’m trying to get other opinions on $WTO after the recent offering-related selloff.

This is not a long-term investment thesis. I understand the risks here: dilution, reverse splits, weak trend, and the possibility that the stock continues to bleed. I’m looking at it strictly as a high-risk post-offering volatility/rebound setup.

A few volume points that stood out to me:

• Monday had roughly 28M shares traded
• Yesterday’s regular-session volume was only around 121K shares
• After hours yesterday, there appeared to be roughly 150K shares traded
• During that after-hours session, price moved from sub-$1.00 into the $1.30s, then faded back down

What I’m trying to figure out is whether that after-hours move was meaningful or just a thin-liquidity spike.

My current read:

The bullish case is that the stock is extremely oversold, volume recently showed there is still interest, and the after-hours push proved it can move quickly when buyers step in.

The bearish case is that the move into the $1.30s failed immediately, which may mean sellers used the spike as exit liquidity. The offering price around $1.20 may also act as resistance unless regular-hours volume confirms a real reclaim.

Levels I’m watching:

• $1.00 — psychological reclaim/hold level
• $1.20 — offering-price area
• $1.30–$1.35 — after-hours rejection zone
• Below $0.90 — would make the bounce case weaker to me

For anyone else watching WTO, how would you interpret the after-hours volume? Does the move from sub-$1.00 to the $1.30s matter, or was it most likely just a thin-book liquidity pop that got sold into?

Not financial advice. High-risk microcap setup. Just looking for chart/tape opinions.

I’m looking for feedback on $WTO as a high-risk Monday watchlist setup.

On Friday, $WTO traded unusually heavy volume after the company announced a registered direct offering. The offering is priced at $1.20 per share for 1,000,000 Class A ordinary shares, with closing expected on or about Monday, May 4, 2026.

What stood out to me:

• Friday volume was around 28.8M
• Scanner showed roughly 14.5x normal volume
• Price was around $1.47 after a sharp selloff
• Offering price is $1.20
• The company has recent reverse-split history
• The stock has shown extreme volatility in the past

My main question is whether the offering-related selloff is already mostly priced in, or whether this continues lower after the offering closes.

The levels I’m watching are:

• $1.20 — offering price / possible downside magnet
• $1.50 — near Friday close area
• $1.75–$2.00 — first reclaim zone
• $3.00 — higher-risk momentum target only if volume confirms

To be clear, I’m not presenting this as a safe play or a long-term investment. This is a speculative penny stock with dilution risk, reverse-split history, and major downside risk. I’m posting because I want other opinions on whether this is simply a dilution dump or whether there is a short-term post-offering reversal setup.

Would appreciate any bearish or bullish takes, especially from anyone who has traded similar registered-direct-offering setups.

Not financial advice.

$WTO — High-Volume Watch for Monday After Registered Direct Offering

$WTO caught my attention heading into Monday, May 4.

Friday’s scanner data showed unusually heavy activity:

• 28.8M volume
• 14.5x normal volume
• Multiple scanner alerts in the final hour
• Closed around $1.47, down roughly 19%
• Biggest 60-minute move flagged at about -12.7%

The catalyst appears to be UTime Limited’s registered direct offering announced May 1. The company is selling 1,000,000 Class A ordinary shares, or pre-funded warrants in lieu of shares, at $1.20 per share, with closing expected on or about May 4, 2026. Gross proceeds are expected to be about $1.2 million before fees and expenses.

This is obviously dilution-related pressure, so the risk is real. But that is also why I’m watching it. The stock has already taken a hard hit, volume exploded, and Monday’s offering-close date could create another volatile session.

Additional context: WTO also completed a 1-for-5 reverse split effective February 17, 2026, so this is a very low-float/high-volatility type of name where moves can get exaggerated fast.

I’m not saying this is a clean long setup. It’s risky, dilution-heavy, and could absolutely keep bleeding. But with the volume spike, offering price at $1.20, Friday close near $1.47, and Monday being the expected closing date, I think it is worth having on the radar.

Personally, I’m watching to see whether buyers can reclaim the $1.50–$1.75 area and build enough momentum for another push back toward $3.00. That would likely require serious volume and a fast shift in sentiment, but given how violently this ticker has moved before, I don’t think it’s impossible.

What are you all seeing here?

Is this just another dilution dump, or is there enough volume/attention for a strong reversal attempt?

Ticker: $WTO
Plan: Watching price action around $1.20–$1.50 Monday
Upside area I’m watching: possible momentum push toward $3.00
Risk: Offering/dilution, reverse-split history, extreme volatility

Not financial advice. High-risk trade.